Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: In vivo delivery of human α-L-iduronidase in mice implanted with neo-organs
Other Titles: In vivo delivery of human alpha-L-iduronidase in mice implanted with neo-organs
Author: Salvetti, A.
Moullier, P.
Cornet, V.
Brooks, D.
Hopwood, J.
Danos, O.
Heard, J.M.
Citation: Human Gene Therapy, 1995; 6(9):1153-1159
Publisher: Mary Ann Liebert
Issue Date: 1995
ISSN: 1043-0342
Statement of
Anna Salvetti, Philippe Moullier, Véronique Cornet, Doug Brooks, John J. Hopwood, Olivier Danos, Jean-Michel Heard
Abstract: Mucopolysaccharidose type I is a lysosomal storage disease caused by a deficiency in the enzyme alpha-l-iduronidase (IDUA). The existence of a secretory pathway for lysosomal enzymes and the capture of secreted molecules by distant cells through binding to mannose-6-phosphate receptors have provided a rationale for enzyme replacement therapy in lysosomal storage diseases. We have used genetically modified fibroblasts implanted into neo-organs as an in vivo delivery system for IDUA. The human IDUA cDNA was isolated and inserted into a retroviral vector where it was expressed from the phosphoglycerate kinase 1 gene promoter. MPS I fibroblasts transduced with this vector showed high levels of IDUA activity and secreted phosphory-lated molecules that could be internalized by naive deficient cells. Neo-organs containing 2 x 107 IDUA-secreting cells were implanted into nude mice. Human and murine IDUA activities were measured in the liver and spleen of animals sacrificed 35-77 days after implantation. Human IDUA activity corresponded to 0.6-2.3% of the murine enzyme activity in the liver and to 0.1-0.3% in the spleen. These data indicated that human IDUA was secreted from neo-organs and internalized in distant tissues. An approach for enzyme replacement in mucopolysaccharidose type I (MPS I) has been examined. Skin fibroblasts were transduced with a retroviral vector containing the human alpha-l-iduronidase cDNA and implanted as neo-organs in nude mice. The presence of the human enzyme in the liver and spleen was detected in treated animals. These data suggest that the implantation of engineered fibroblasts into neo-organs may be of a therapeutic benefit in MPS.
Keywords: Liver
Cells, Cultured
Mice, Nude
Lysosomal Storage Diseases
DNA, Complementary
Cell Transplantation
Transplantation, Autologous
Gene Transfer Techniques
Transduction, Genetic
Gene Expression
Base Sequence
Genetic Vectors
Molecular Sequence Data
Promoter Regions, Genetic
Rights: Copyright status unknown
DOI: 10.1089/hum.1995.6.9-1153
Appears in Collections:Aurora harvest
Paediatrics publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.